서흥

008490KOSPI기타 화학제품 제조업

61.0 / 100

Reference Date: 2026-04-13

Financial Score28.5 / 40

News Sentiment12.5 / 25

Momentum10.0 / 20

Disclosure10.0 / 15

AI Analysis: PER is significantly undervalued vs. peers but the high debt ratio poses financial risk. Declined 12.7% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Seohyang operates in hard capsule manufacturing, pharmaceutical contract production, health functional food production, raw materials, and cosmetics. It holds a dominant 95% market share in domestic hard capsule production and ranks third globally. Key products include hard and soft capsules, health functional foods, gelatin, collagen, and cosmetics, driven by growing demand for health and beauty solutions due to aging populations.

Number of Employees

1,295people

Average Salary

52.7M KRW

Score Calculation Basis

Detailed Financial Score

PER

4.57Industry Average 18.388.0Point

Half of industry avg (excellent)

PBR

0.38Industry Average 1.377.0Point

Half of industry avg (excellent)

ROE

8.99Industry Average 4.555.5Point

2.0x industry avg (good)

Debt Ratio

28.26Industry Average 8.130.0Point

3.5x industry avg (risky)

Trend 2023~20258.0 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲10.2% (2-year basis)

Operating Profit Growth Rate

2.5 / 3

Avg ▲13.5% (2-year basis)

ROE Trend

3.0 / 4

Avg ROE 5.1% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position3.0Point

52w lower range (26%)

Current 17,860Won52-week high 31,10052-week low 13,020

1-month return1.0Point

1m -12.67% (falling)

Volume trend6.0Point

Volume surge

Detailed Disclosure

5 totalPositive 0Neutral 5Negative 0

Neutral주식등의대량보유상황보고서(약식)2026-04-09
Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-27
Neutral정기주주총회결과2026-03-27
Neutral사업보고서 (2025.12)2026-03-19
Neutral감사보고서제출2026-03-17